Neues in der Asthma-Grundversorgung [Novelties in the Treatment of Asthma]

Details

Serval ID
serval:BIB_88B5040B3CB3
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Neues in der Asthma-Grundversorgung [Novelties in the Treatment of Asthma]
Journal
Praxis
Author(s)
Leuppi J.D., Bridevaux P.O., Charbonnier F., Clarenbach C., Duchna H.W., Gianella P., Jochmann A., Kern L., Meyer F., Pavlov N., Rothe T., Steurer-Stey C., Garnier C.V.
ISSN
1661-8157 (Print)
ISSN-L
1661-8157
Publication state
Published
Issued date
2021
Peer-reviewed
Oui
Volume
110
Number
16
Pages
967-974
Language
german
Notes
Publication types: Journal Article
Publication Status: ppublish
Abstract
Novelties in the Treatment of Asthma Abstract. For general practitioners there have been important novelties in the treatment of asthma due to recent modifications of the international guidelines from Global Initiative for Asthma (GINA). Step 1 no longer recommends the use of short-acting β2-agonists (SABA) without concomitant inhaled corticosteroids (ICS) as a controller because of the lack of efficacy and for safety reasons. Instead, low dose ICS-formoterol as needed is recommended. GINA step 5 recommends targeted biologic therapies like interleukin antibodies in patients with severe uncontrolled asthma. Asthma patients presenting simultaneously with symptoms of chronic obstructive pulmonary disease (COPD) should receive treatment containing ICS. Independent of the current corona pandemic, GINA recommendations stay in place. Recent data on prescriptions of SABA and oral corticosteroids (OCS) in Switzerland indicate that they still play an important role in asthma management and that GINA recommendations have not yet been sufficiently implemented into practice.
Keywords
Administration, Inhalation, Adrenal Cortex Hormones/therapeutic use, Anti-Asthmatic Agents/adverse effects, Asthma/drug therapy, Formoterol Fumarate/therapeutic use, Humans, Allgemeinpraktiker/Allgemeinpraktikerin, Asthma, Asthme, Biologika, GINA recommendations, GINA-Empfehlung, Stufentherapie, biologics, general practitioner, médecin de premier recours, recommandations GINA, stepwise treatment approach, thérapies biologiques, traitement de fond par paliers
Pubmed
Open Access
Yes
Create date
06/11/2021 16:27
Last modification date
02/12/2023 7:16
Usage data